How should hydroxocobalamin be administered intravenously for cyanide poisoning in adults and children, including dosage, dilution, infusion rate, and repeat dosing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Hydroxocobalamin Administration for Cyanide Poisoning

Hydroxocobalamin should be administered intravenously at 5 grams over 15 minutes for adults, with a second 5-gram dose given over 15 minutes to 2 hours if needed, for a maximum total dose of 10 grams. 1

Adult Dosing Protocol

Initial dose: 5 grams IV infused over 15 minutes

Repeat dosing: A second 5-gram dose may be administered over 15 minutes to 2 hours depending on severity of poisoning and clinical response, for a maximum total of 10 grams 1

The 2023 American Heart Association guidelines establish hydroxocobalamin as the primary recommended treatment for suspected cyanide poisoning, particularly in smoke inhalation victims where concurrent carbon monoxide poisoning is common 1. This recommendation is based on hydroxocobalamin's superior safety profile—it does not cause hypotension or worsen oxygen-carrying capacity like alternative antidotes 1.

Pediatric Dosing

Initial dose: 70 mg/kg IV (maximum 5 grams) infused over 15 minutes

Repeat dosing: A second dose of 70 mg/kg (maximum 5 grams) may be given over 15 minutes to 2 hours based on clinical severity, for a maximum total of 140 mg/kg or 10 grams

Preparation and Administration Details

  • Dilution: Reconstitute each 5-gram vial with 200 mL of 0.9% sodium chloride
  • Infusion rate: Administer via IV push or infusion over 15 minutes for the initial dose
  • Line protection: The solution is light-sensitive; protect from light during administration
  • Visual inspection: The solution should appear dark red; inspect for particulate matter before administration

Critical Timing Considerations

Administer without delay when cyanide poisoning is suspected—do not wait for confirmatory laboratory testing 1. Research demonstrates significant delays in real-world practice (median 208 minutes in one study), and longer time to administration was associated with increased mortality 2. Cases receiving hydroxocobalamin within 60 minutes had better outcomes 2.

Adjunctive Therapy

Sodium thiosulfate: It is reasonable to administer 12.5 grams IV in addition to hydroxocobalamin, as it enhances cyanide elimination through a complementary mechanism 1. While sodium thiosulfate acts too slowly for monotherapy, the combination may provide synergistic benefit—hydroxocobalamin provides immediate effect while sodium thiosulfate offers delayed but persistent action 3.

100% oxygen: Administer concurrently, as it is reasonable therapy even with normal oxygen saturation, given cyanide's mechanism as a cellular poison that impairs mitochondrial respiration 1.

Clinical Indications for Administration

Suspect cyanide poisoning and treat empirically in patients with:

  • Smoke inhalation with soot in face, mouth, nose, or expectorations
  • Altered mental status, seizures, or cardiovascular collapse
  • Metabolic acidosis with elevated lactate
  • Known exposure to industrial cyanide sources

Do not delay treatment for laboratory confirmation—blood cyanide levels are not rapidly available and treatment must be initiated based on clinical suspicion 1, 4.

Safety Profile and Adverse Effects

Hydroxocobalamin is remarkably safe with predominantly benign, self-limiting effects 5:

Common (expected):

  • Chromaturia (red/pink urine discoloration)
  • Transient red skin discoloration
  • Mucous membrane discoloration

Clinically significant:

  • Transient hypertension: Mean increases of 23-27 mmHg systolic and 14-25 mmHg diastolic, peaking at end of infusion and typically resolving within 4 hours 5
  • Allergic reactions: Rare but documented; have dexamethasone and antihistamines available 5

Important caveat: Recent concerns about methemoglobinemia after hydroxocobalamin have been investigated, but a 2024 study found no significant association between hydroxocobalamin administration and methemoglobinemia in burn patients with inhalation injury 6. Any observed elevations may be due to co-oximetry interference from the drug's red color or concurrent methemoglobin-inducing medications.

Monitoring

  • Blood pressure during and for 4 hours post-infusion
  • Serum lactate (should decrease rapidly if cyanide poisoning present) 4
  • Arterial blood gases and pH
  • Clinical response (mental status, hemodynamics)

Key Clinical Pitfalls to Avoid

  1. Delaying administration while awaiting laboratory confirmation—treat empirically based on clinical suspicion
  2. Underdosing in severe poisoning—use the full 5-gram initial dose and consider the second dose early
  3. Withholding treatment due to concerns about methemoglobinemia—this is not a clinically significant risk 6
  4. Using sodium nitrite as first-line when hydroxocobalamin is available—sodium nitrite causes hypotension and methemoglobinemia, making it inferior in smoke inhalation where CO poisoning coexists 1

References

Related Questions

What are the recommended hydroxocobalamin dosing regimens for acute cyanide poisoning and for vitamin B12 deficiency in adults and children?
What is the recommended intravenous (IV) dosage of hydroxocobalamin for treating cyanide poisoning?
How does cyanide enter the mitochondrial matrix?
How does Cyanokit (hydroxocobalamin) increase Systemic Vascular Resistance (SVR) in shock?
What stable compound is formed by the reaction between hydroxocobalamin and cyanide?
Could nightly use of zopiclone and clonazepam contribute to orthostatic hypotension in a patient also taking tamsulosin?
What oral dosage strengths of mefenamic acid are commercially available?
In a healthy adult with severe dental pain, which NSAID is preferred: ibuprofen or mefenamic acid?
What does a high base excess on an arterial blood gas indicate?
In a 24-year-old woman with irregular intermenstrual bleeding and spotting, what is the appropriate diagnostic work-up and initial management?
How should a transdermal fentanyl patch be converted to an intravenous fentanyl infusion in an opioid‑tolerant patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.